Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Cheung

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based StudyAbi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, et al.
British Journal of Haematology|May 17, 2018
Azacitidine in the 'real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, CanadaLee Mozessohn, Matthew C Cheung, Saber Fallahpour, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials GroupLouis Everest, Scott Blommaert, Dongsheng Tu, et al.
British Journal of Haematology|July 20, 2023
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in OntarioAdam Suleman, Suriya J Aktar, Zharmaine Ante, et al.
Cancer Medicine|May 28, 2019
The impact of pricing strategy on the costs of oral anti-cancer drugsJudy Truong, Kelvin K W Chan, Helen Mai, et al.
Journal of Oncology Practice|June 13, 2017
Financial Impact of Cancer Drug Wastage and Potential Cost Savings From Mitigation StrategiesCaitlyn Y W Leung, Matthew C Cheung, Lauren F Charbonneau, et al.
Leukemia & Lymphoma|April 24, 2020
Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, CanadaAniket Bankar, Haoyu Zhao, Javaid Iqbal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2012
Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experimentNina Lathia, Pierre K Isogai, Scott E Walker, et al.
Leukemia & Lymphoma|January 24, 2014
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosisLee Mozessohn, Matthew C Cheung, Michael Crump, et al.
Journal of Surgical Oncology|November 12, 2024
Preoperative Anemia and Iron Deficiency in Elective Gastrointestinal Cancer Surgery PatientsClarissa P Skorupski, Matthew C Cheung, Julie Hallet, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based StudyAbi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, et al.
British Journal of Haematology|May 17, 2018
Azacitidine in the 'real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, CanadaLee Mozessohn, Matthew C Cheung, Saber Fallahpour, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 2, 2022
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials GroupLouis Everest, Scott Blommaert, Dongsheng Tu, et al.
British Journal of Haematology|July 20, 2023
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in OntarioAdam Suleman, Suriya J Aktar, Zharmaine Ante, et al.
Cancer Medicine|May 28, 2019
The impact of pricing strategy on the costs of oral anti-cancer drugsJudy Truong, Kelvin K W Chan, Helen Mai, et al.
Journal of Oncology Practice|June 13, 2017
Financial Impact of Cancer Drug Wastage and Potential Cost Savings From Mitigation StrategiesCaitlyn Y W Leung, Matthew C Cheung, Lauren F Charbonneau, et al.
Leukemia & Lymphoma|April 24, 2020
Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, CanadaAniket Bankar, Haoyu Zhao, Javaid Iqbal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2012
Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experimentNina Lathia, Pierre K Isogai, Scott E Walker, et al.
Leukemia & Lymphoma|January 24, 2014
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosisLee Mozessohn, Matthew C Cheung, Michael Crump, et al.
Journal of Surgical Oncology|November 12, 2024
Preoperative Anemia and Iron Deficiency in Elective Gastrointestinal Cancer Surgery PatientsClarissa P Skorupski, Matthew C Cheung, Julie Hallet, et al.
Pageof 15